UK Markets closed

Cresco Labs Inc. (CRLBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.4800-0.1000 (-2.79%)
At close: 03:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.04
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 311.0050
52-week low 32.4200
50-day moving average 33.2424
200-day moving average 35.6101

Share statistics

Avg vol (3-month) 3437.26k
Avg vol (10-day) 3319.86k
Shares outstanding 5253.13M
Implied shares outstanding 6N/A
Float 8265.2M
% held by insiders 123.54%
% held by institutions 15.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:812
Last split date 302 Dec 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -37.78%
Operating margin (ttm)13.83%

Management effectiveness

Return on assets (ttm)4.55%
Return on equity (ttm)-40.21%

Income statement

Revenue (ttm)840.68M
Revenue per share (ttm)3.05
Quarterly revenue growth (yoy)20.10%
Gross profit (ttm)429.79M
EBITDA 155.74M
Net income avi to common (ttm)-317.58M
Diluted EPS (ttm)-1.3730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)179.32M
Total cash per share (mrq)0.61
Total debt (mrq)640.52M
Total debt/equity (mrq)83.86
Current ratio (mrq)1.21
Book value per share (mrq)1.98

Cash flow statement

Operating cash flow (ttm)-1.88M
Levered free cash flow (ttm)-35.84M